Related Experiment Video
Updated: Dec 25, 2025

Avocado Sample Preparation Using the QuEChERS Method with Ammonium Formate for Pesticide Analysis
Published on: December 8, 2023
Abstract:
The Food Safety Commission of Japan (FSCJ) conducted a risk assessment of mepanipyrim (CAS No.110235-47-7), an anilinopyrimidine fungicide, based on results from various studies. Major adverse effects of mepanipyrim observed were hepatocellular hypertrophy, hepatocellular degeneration, and increased kidney weight in rats. Neither reproductive toxicity, teratogenicity nor genotoxicity was observed. Mepanipyrim (parent compound only) was identified as a chemical for the residue definition for dietary risk assessment in agricultural products. FSCJ adopted the no-observed-adverse-effect level (NOAEL) of 7.34 mg/kg bw/day, obtained in a two-year combined chronic/carcinogenicity study in rats, appropriate for specification of an acceptable daily intake (ADI). An ADI was thus specified as 0.073 mg/kg bw/day, applying a safety factor of 100 to the NOAEL. The lowest NOAEL for adverse effects that would be likely to be elicited by a single oral administration of mepanipyrim was 400 mg/kg bw obtained in an acute neurotoxicity study in rats. Consequently, FSCJ specified an acute reference dose (ARfD) of 4 mg/kg bw, applying a safety factor of 100 to the NOAEL.
Insights
The Food Safety Commission of Japan assessed mepanipyrim fungicide, finding liver and kidney effects in rats but no reproductive or genetic toxicity. An acceptable daily intake (ADI) and acute reference dose (ARfD) were established.
Area of Science:
- Food Safety
- Toxicology
- Risk Assessment
Background:
- Mepanipyrim (CAS No. 110235-47-7) is an anilinopyrimidine fungicide.
- Dietary risk assessment requires evaluating potential adverse effects of pesticide residues.
Purpose of the Study:
- To conduct a comprehensive risk assessment of mepanipyrim.
- To establish an acceptable daily intake (ADI) and an acute reference dose (ARfD) for mepanipyrim.
Main Methods:
- Reviewed various toxicological studies on mepanipyrim.
- Utilized a two-year combined chronic/carcinogenicity study in rats to determine the no-observed-adverse-effect level (NOAEL).
- Employed an acute neurotoxicity study in rats to identify the lowest NOAEL for single oral administration.
Main Results:
- Major adverse effects in rats included hepatocellular hypertrophy, hepatocellular degeneration, and increased kidney weight.
- No reproductive toxicity, teratogenicity, or genotoxicity was observed.
- The NOAEL from the chronic study was 7.34 mg/kg bw/day, leading to an ADI of 0.073 mg/kg bw/day.
- The lowest NOAEL from acute neurotoxicity was 400 mg/kg bw, resulting in an ARfD of 4 mg/kg bw.
Conclusions:
- Mepanipyrim (parent compound) is the relevant entity for residue definition in dietary risk assessment.
- The established ADI and ARfD provide safety guidelines for mepanipyrim exposure.
- The risk assessment supports the safe use of mepanipyrim within specified limits.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Physical Properties of Amines

